Fingerprint
Dive into the research topics of 'EuroQol-5 dimensions utility gain according to British and Swedish preference sets in rheumatoid arthritis treated with abatacept, rituximab, tocilizumab, or tumour necrosis factor inhibitors: a prospective cohort study from southern Sweden'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically